Prolia 60mg Injection contains Denosumab, a monoclonal antibody used primarily in the treatment of bone-related conditions. Denosumab works by inhibiting a protein involved in bone resorption, making it useful in conditions where bone density needs to be preserved or enhanced.
Prolia 60mg Injection contains Denosumab, a monoclonal antibody used primarily in the treatment of bone-related conditions.
Brand Name: Prolia
Composition: Denosumab
Mechanism of Action:
Denosumab is a RANK ligand (RANKL) inhibitor that binds to and inactivates RANKL, a protein essential for the formation, function, and survival of osteoclasts (cells that break down bone). By inhibiting RANKL, Denosumab reduces bone resorption and increases bone density, thereby lowering the risk of fractures.
Uses:
· Osteoporosis
· Bone Loss
· Giant Cell Tumor of Bone
· Hypercalcemia of Malignancy
Dosage and Administration:
60 mg subcutaneously once every 6 months for osteoporosis; other conditions may have different dosing schedules. Administered as a subcutaneous injection in the upper arm, upper thigh, or abdomen.
Side Effects:
· Back pain
· Musculoskeletal pain
· High cholesterol
· Urinary tract infections
· Rash
· Hypocalcemia (low blood calcium levels)
· Osteonecrosis of the jaw
· Femur fractures
· Hair loss
· Nerve Pain
Boost your visibility and reach more customers by listing your business with us. It's quick, easy, and absolutely free! Join thousands of businesses benefiting from our platform.
Add My Business arrow_forwardCopyright © 2026 Plumint.